| # | Drug | Count |
|---|---|---|
| 0 | EMPAGLIFLOZIN | 45 |
| 1 | METHOTREXATE SODIUM | 43 |
| 2 | METHOTREXATE | 40 |
| 3 | CYCLOPHOSPHAMIDE | 24 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 24 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 24 |
| 6 | ACETAMINOPHEN | 23 |
| 7 | DEXAMETHASONE | 20 |
| 8 | DEXAMETHASONE 1.5 MG | 20 |
| 9 | ACETAMINOPHEN 500MG | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMCINONIDE | 2 | 0.0235 |
| 1 | SODIUM HYPOCHLORITE | 1 | 0.0038 |
| 2 | CLINDAMYCIN PHOSPHATE | 18 | 0.0033 |
| 3 | HYDROCORTISONE BUTYRATE | 5 | 0.0025 |
| 4 | DIMENHYDRINATE | 17 | 0.0016 |
| 5 | PEGASPARGASE | 19 | 0.0015 |
| 6 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 4 | 0.0014 |
| 7 | PURIXAN | 1 | 0.0013 |
| 8 | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 4 | 0.0011 |
| 9 | ERTUGLIFLOZIN | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 59 |
| 1 | Corticosteroid [EPC] | 46 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 40 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 32 |
| 4 | Alkylating Drug [EPC] | 26 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 26 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 22 |
| 7 | Vitamin C [EPC] | 20 |
| 8 | Asparagine-specific Enzyme [EPC] | 19 |
| 9 | Benzodiazepine [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Asparagine-specific Enzyme [EPC] | 19 | 0.0014 |
| 1 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 59 | 0.0005 |
| 2 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 15 | 0.0002 |
| 3 | Histamine-1 Receptor Antagonist [EPC] | 13 | 0.0002 |
| 4 | Epidermal Growth Factor Receptor Antagonist [EPC] | 7 | 0.0001 |
| 5 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 16 | 0.0001 |
| 7 | Aldosterone Antagonist [EPC] | 18 | 0.0001 |
| 8 | Nuclear Export Inhibitor [EPC] | 1 | 0.0001 |
| 9 | Angiotensin Converting Enzyme Inhibitor [EPC] | 15 | 0.0001 |